Chemed Co. (NYSE:CHE) Shares Acquired by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC increased its holdings in Chemed Co. (NYSE:CHE - Free Report) by 9.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 46,052 shares of the company's stock after acquiring an additional 3,785 shares during the quarter. Allspring Global Investments Holdings LLC owned approximately 0.31% of Chemed worth $24,314,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. International Assets Investment Management LLC acquired a new position in Chemed in the third quarter valued at $437,150,000. FMR LLC increased its position in Chemed by 23.8% in the 3rd quarter. FMR LLC now owns 238,616 shares of the company's stock valued at $143,401,000 after acquiring an additional 45,917 shares during the period. Thrivent Financial for Lutherans grew its stake in shares of Chemed by 25.3% in the 3rd quarter. Thrivent Financial for Lutherans now owns 146,017 shares of the company's stock valued at $87,752,000 after purchasing an additional 29,445 shares during the last quarter. Aureus Asset Management LLC grew its position in Chemed by 3,147.2% in the 3rd quarter. Aureus Asset Management LLC now owns 29,939 shares of the company's stock valued at $17,993,000 after buying an additional 29,017 shares during the last quarter. Finally, Boston Trust Walden Corp increased its stake in shares of Chemed by 10.0% during the fourth quarter. Boston Trust Walden Corp now owns 242,172 shares of the company's stock worth $128,303,000 after acquiring an additional 22,105 shares during the period. 95.85% of the stock is owned by institutional investors and hedge funds.

Chemed Price Performance

Shares of CHE stock traded up $6.23 during midday trading on Wednesday, reaching $556.57. 57,643 shares of the company traded hands, compared to its average volume of 86,403. The firm has a market cap of $8.38 billion, a PE ratio of 28.12, a price-to-earnings-growth ratio of 2.16 and a beta of 0.48. The firm's 50 day simple moving average is $542.45 and its two-hundred day simple moving average is $564.40. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $654.62.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a yield of 0.36%. Chemed's payout ratio is 10.11%.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on CHE shares. Royal Bank of Canada dropped their price objective on Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a report on Tuesday, November 5th. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a research note on Saturday, November 30th.

Insider Buying and Selling at Chemed

In other Chemed news, VP Brian C. Judkins acquired 145 shares of the firm's stock in a transaction that occurred on Monday, December 30th. The shares were acquired at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the transaction, the vice president now directly owns 1,678 shares of the company's stock, valued at approximately $871,721. This represents a 9.46 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm's stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the transaction, the chief executive officer now owns 101,735 shares of the company's stock, valued at $58,270,755.95. This trade represents a 1.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.32% of the stock is owned by corporate insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.